Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-06-17 | Mr. Madhavan BalachandranIndependent Non-Executive Director | -11,69k | 234,68k | Derivative Exercise and Sale | 19,39 - 47,08 | 43,25k | - |
| 2026-06-15 | Mr. Madhavan BalachandranIndependent Non-Executive Director | -10,00k | 193,60k | Derivative Exercise and Sale | 8,49 - 27,85 | 43,25k | - |
| 2026-06-15 | Dr. Jeannette PottsChief Legal & Compliance Officer and Corporate Secretary | -5,24k | 144,91k | Verkauf | 27,67 | 58,01k | -8,28% |
| 2026-06-11 | Mr. David D. MeekIndependent Chairman of the Board | -1,99k | 53,93k | Verkauf | 27,06 | 32,20k | -5,83% |
| 2026-06-10 | Dr. Robert GutNon-Executive Director | -4,91k | 127,76k | Automatic Disposition | 26,03 - 26,05 | 24,71k | -16,57% |
| 2026-06-11 | Dr. Robert GutNon-Executive Director | -2,73k | 73,77k | Verkauf | 27,06 | 24,71k | -9,94% |
| 2026-06-10 | Dr. Robert GutNon-Executive Director | -2,65k | 26,53k | Derivative Exercise and Sale | 16,04 - 26,07 | 24,71k | - |
| 2026-06-11 | Ms. Kylie O'KeefeChief Customer & Strategy Officer | -15,94k | 431,23k | Verkauf | 27,06 | 108,86k | -12,77% |
| 2026-06-11 | Dr. Jeremy P. SpringhornIndependent Non-Executive Director | -1,99k | 53,93k | Verkauf | 27,06 | 35,70k | -5,29% |
| 2026-06-11 | Dr. Leonard E. PostIndependent Non-Executive Director | -1,99k | 53,93k | Verkauf | 27,06 | 27,94k | -6,66% |
| 2026-06-11 | Mr. Jack L. KayeIndependent Non-Executive Director | -1,99k | 53,93k | Verkauf | 27,06 | 18,45k | -9,75% |
| 2026-06-11 | Ms. Rachelle Suzanne JacquesNon-Executive Director | -1,99k | 53,93k | Verkauf | 27,06 | 26,35k | -7,03% |
| 2026-06-11 | Mr. Madhavan BalachandranIndependent Non-Executive Director | -1,99k | 53,93k | Verkauf | 27,06 | 35,70k | -5,29% |
| 2026-06-03 | Mr. Jack L. KayeIndependent Non-Executive Director | -2,65k | 36,95k | Derivative Exercise and Sale | 16,04 - 30,01 | 12,47k | - |
| 2026-05-08 | Dr. Walid Abi-SaabChief Medical Officer | -25,00k | 487,75k | Derivative Exercise and Sale | 5,59 - 25,10 | 169,67k | - |
| 2026-05-08 | Dr. Walid Abi-SaabChief Medical Officer | -20,00k | 500,00k | Automatic Disposition | 25,00 | 169,67k | -10,54% |
| 2026-03-04 | Mr. Matthew Craig KapustaCEO & Executive Director | -14,58k | 132,10k | Verkauf | 9,06 | 474,06k | -2,98% |
| 2026-03-04 | Dr. Walid Abi-SaabChief Medical Officer | -808,00 | 7,32k | Verkauf | 9,06 | 189,67k | -0,42% |
| 2026-03-04 | Dr. Jeannette PottsChief Legal & Compliance Officer and Corporate Secretary | -3,41k | 30,91k | Verkauf | 9,06 | 47,55k | -6,70% |
| 2026-03-04 | Mr. Christian KlemtCFO, Principal Financial Officer & GM of Amsterdam Site | -12,00k | 108,72k | Verkauf | 9,06 | 121,81k | -8,97% |
| 2026-03-02 | Mr. Matthew Craig KapustaCEO & Executive Director | -34,44k | 342,65k | Verkauf | 9,95 | 455,64k | -7,03% |
| 2026-03-02 | Mr. Christian KlemtCFO, Principal Financial Officer & GM of Amsterdam Site | -12,53k | 124,69k | Verkauf | 9,95 | 109,48k | -10,27% |
| 2026-03-02 | Dr. Jeannette PottsChief Legal & Compliance Officer and Corporate Secretary | -8,58k | 85,35k | Verkauf | 9,95 | 39,30k | -17,92% |
| 2026-03-02 | Dr. Walid Abi-SaabChief Medical Officer | -1,66k | 16,52k | Verkauf | 9,95 | 148,78k | -1,10% |
| 2026-02-25 | Mr. Matthew Craig KapustaCEO & Executive Director | -12,38k | 295,34k | Verkauf | 23,86 | 440,08k | -2,74% |
| 2026-02-25 | Mr. Christian KlemtCFO, Principal Financial Officer & GM of Amsterdam Site | -6,22k | 148,34k | Verkauf | 23,86 | 105,51k | -5,56% |
| 2026-01-12 | Dr. Robert GutNon-Executive Director | -17,81k | 183,94k | Derivative Exercise and Sale | 14,08 - 25,03 | 24,37k | - |
| 2026-01-12 | Dr. Robert GutNon-Executive Director | -7,80k | 195,78k | Automatic Disposition | 25,09 | 24,37k | -24,25% |
| 2026-01-09 | Mr. Jack L. KayeIndependent Non-Executive Director | -6,39k | 50,42k | Derivative Exercise and Sale | 19,39 - 27,28 | 12,47k | - |
| 2025-11-06 | Dr. Robert GutNon-Executive Director | -15,84k | 358,78k | Derivative Exercise and Sale | 4,57 - 27,22 | 32,18k | - |
| 2025-11-06 | Dr. Robert GutNon-Executive Director | -15,59k | 425,72k | Automatic Disposition | 27,30 | 32,18k | -32,64% |
| 2025-11-04 | Mr. Jack L. KayeIndependent Non-Executive Director | -38,81k | 793,98k | Derivative Exercise and Sale | 5,37 - 30,36 | 12,47k | - |
| 2025-09-24 | Mr. Matthew Craig KapustaCEO & Executive Director | -226,32k | 7,91M | Derivative Exercise and Sale | 6,22 - 45,10 | 411,95k | - |
| 2025-09-24 | Mr. Christian KlemtCFO, Principal Financial Officer & GM of Amsterdam Site | -18,00k | 825,48k | Derivative Exercise and Sale | 5,37 - 55,00 | 99,26k | - |
| 2025-06-27 | Dr. Walid Abi-SaabChief Medical Officer | -1,47k | 20,41k | Verkauf | 13,92 | 150,44k | -0,97% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
